covaxin

DNA: Why is Covaxin not getting World Health Organization's recognition?

Covaxin has been developed by the Hyderabad-based Bharat Biotech company, which sent the vaccine data to the WHO for the first time on July 09 and sought approval for emergency use of the vaccine. The vaccine recognition process takes 6 to 9 weeks, but even after 3 months, no decision has been taken so far.

Oct 29, 2021, 23:40 PM IST

DNA Exclusive: Is WHO biased against India's Covaxin? Read here

Zee News Editor-in-Chief Sudhir Chaudhary on Friday analysed if the World Health Organisation is biased towards Covaxin even as Bharat Biotech awaits its approval for emergency use lisitng.

Oct 29, 2021, 23:12 PM IST

‘Bharat Biotech submitting data regularly, very quickly': WHO official on Covaxin approval

"Let me say that Bharat has been submitting data regularly and very quickly, but they submitted the last batch of data on the 18th of October," Dr Mariangela Simao, Assistant Director-General said. 

Oct 29, 2021, 07:26 AM IST

Covaxin added to approved list by Oman, no quarantine for travelers from India

Indian travelers will no longer be required to quarantine if they have received both doses of Covaxin.

Oct 27, 2021, 21:21 PM IST

WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin's emergency use approval

The World Health Organisation's technical advisory group will now meet on November 3 for a final assessment.

Oct 27, 2021, 07:48 AM IST

WHO meet on Covaxin emergency use approval today, decision likely within 24 hours

A WHO technical advisory group was reviewing data on Covaxin shot against COVID-19 today with a decision on its emergency use listing likely soon, a spokesperson said.

Oct 26, 2021, 17:13 PM IST

Emergency use listing for Covaxin: WHO's technical advisory group to decide today

It’s expected that the technical advisory group will most likely consider granting the EUL for Covaxin in today's meeting. A top WHO official had earlier said that the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.

Oct 26, 2021, 06:48 AM IST

As India awaits EUL nod for Covaxin, WHO says ‘decision may take longer time’

WHO Chief Scientist Soumya Swaminathan had said in a tweet earlier that the technical advisory group at WHO will meet on October 26 to consider the Emergency Use Listing for Covaxin being manufactured by India's Bharat Biotech.

Oct 22, 2021, 13:12 PM IST

‘Cannot cut corners' in approving Covaxin, expecting more info from Bharat Biotech: WHO

WHO said, "we are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID-19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective."

Oct 18, 2021, 23:24 PM IST

WHO group to meet on October 26 to consider Covaxin's emergency listing

"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere," WHO Chief Scientist said in a tweet. 

Oct 17, 2021, 23:40 PM IST

India to procure over 30 crore COVID-19 vaccine doses per month by January: Sources

India will have a capacity of more than 30 crores by next year per month, which includes Covishield, Covaxin, ZyCoV-D and Biological E, said sources. 

Oct 16, 2021, 15:33 PM IST

Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources

Bharat Biotech in an official statement had said they are waiting for further approvals from drug regulators.

Oct 14, 2021, 20:54 PM IST

COVID-19: Covaxin recommended for 2 to 18-year-olds in India

The development comes amid India closing in on 100 crore vaccination coverage.

Oct 12, 2021, 13:31 PM IST

‘Covaxin trials on children show similar results as on adults’

Dr Rai noted that globally it is observed that in children, SARS-CoV-2 isn`t fatal.

Oct 11, 2021, 20:33 PM IST

WHO to take decision on Covaxin next week

"WHO and an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," tweeted the world health body

Oct 05, 2021, 21:45 PM IST

WHO's emergency use nod to Covaxin: Expert panel to decide today

Documents detailing the WHO expert committee's agenda for the meeting show that it will discuss the assessment status of pending applications for vaccine candidates, including Covaxin.

Oct 05, 2021, 09:01 AM IST

India to make a record of 100 crore vaccinations

We are breaking our own record in the Corona Vaccination case, know how close we are to the record 100 crore figure.

Oct 03, 2021, 17:00 PM IST

Mamata Banerjee's Chief Ministerial post at stake, Yashasvi Jaiswal unlocks milestone, check today’s top headlines

West Bengal Chief Minister Mamata Banerjee's fate will be decided today (October 3) as the results for the crucial Bhabanipur by-election will be announced. In other news, paddy procurement will commence in the states of Haryana and Punjab. Meanwhile, Rajasthan Royals batter Yashasvi Jaiswal went on to complete his maiden IPL fifty, reaching the milestone in just 19 deliveries.

Oct 03, 2021, 07:19 AM IST

WHO likely to give emergency use authorisation to Covaxin this month, top experts say

"WHO will give the approval soon as it is a `killed vaccine` which has been approved earlier also by other names from other countries, said Chairperson of the COVID Task Force for AIIMS, Delhi.

Oct 02, 2021, 22:40 PM IST